147 related articles for article (PubMed ID: 19943145)
1. Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience.
Satoh T; Ishiyama H; Matsumoto K; Tabata K; Kitano M; Iwamura M; Kimura M; Minamida S; Yamashita H; Matsuda D; Kotani S; Niibe Y; Uemae M; Hayakawa K; Baba S
Jpn J Radiol; 2009 Nov; 27(9):348-54. PubMed ID: 19943145
[TBL] [Abstract][Full Text] [Related]
2. [Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy].
Becerra Bachino V; Cots F; Guedea F; Pera J; Boladeras A; Aguiló F; Suárez JF; Gallo P; Murgui L; Pont A; Cunillera O; Pardo Y; Ferrer M;
Gac Sanit; 2011; 25(1):35-43. PubMed ID: 21316126
[TBL] [Abstract][Full Text] [Related]
3. Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness.
Norderhaug I; Dahl O; Høisaeter PA; Heikkilä R; Klepp O; Olsen DR; Kristiansen IS; Waehre H; Bjerklund Johansen TE
Eur Urol; 2003 Jul; 44(1):40-6. PubMed ID: 12814673
[TBL] [Abstract][Full Text] [Related]
4. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
[TBL] [Abstract][Full Text] [Related]
5. Cost implications of the rapid adoption of newer technologies for treating prostate cancer.
Nguyen PL; Gu X; Lipsitz SR; Choueiri TK; Choi WW; Lei Y; Hoffman KE; Hu JC
J Clin Oncol; 2011 Apr; 29(12):1517-24. PubMed ID: 21402604
[TBL] [Abstract][Full Text] [Related]
6. Charge and length of hospital stay analysis of radical retropubic prostatectomy and transperineal prostate brachytherapy.
Wagner TT; Young D; Bahnson RR
J Urol; 1999 Apr; 161(4):1216-8. PubMed ID: 10081872
[TBL] [Abstract][Full Text] [Related]
7. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
8. Perioperative costs and charges of prostate brachytherapy and prostatectomy.
Makhlouf AA; Boyd JC; Chapman TN; Theodorescu D
Urology; 2002 Oct; 60(4):656-60. PubMed ID: 12385928
[TBL] [Abstract][Full Text] [Related]
9. A comparative costs analysis of brachytherapy and radical retropubic prostatectomy therapies for clinically localized prostate cancer.
Gianino MM; Galzerano M; Minniti D; Di Novi C; Martin B; Davini O; Barbaro S
Int J Technol Assess Health Care; 2009 Jul; 25(3):411-4. PubMed ID: 19619361
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review.
Becerra V; Ávila M; Jimenez J; Cortes-Sanabria L; Pardo Y; Garin O; Pont A; Alonso J; Cots F; Ferrer M;
BMC Health Serv Res; 2016 Oct; 16(1):541. PubMed ID: 27716267
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy for Localized Prostate Cancer: An Analysis of the ProtecT Trial.
Sharma V; Wymer KM; Borah BJ; Barocas DA; Thompson RH; Karnes RJ; Boorjian SA
J Urol; 2019 Nov; 202(5):964-972. PubMed ID: 31112105
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the cost of various treatment methods for early cancer of the prostate.
Hanks GE; Dunlap K
Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1879-81. PubMed ID: 3759540
[TBL] [Abstract][Full Text] [Related]
13. [Valorisation of brachytherapy and medico-economic considerations].
Pommier P; Morelle M; Millet-Lagarde F; Peiffert D; Gomez F; Perrier L
Cancer Radiother; 2013 Apr; 17(2):178-81. PubMed ID: 23601252
[TBL] [Abstract][Full Text] [Related]
14. Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer.
Ciezki JP; Klein EA; Angermeier KW; Ulchaker J; Zippe CD; Wilkinson DA
Urology; 2000 Jan; 55(1):68-72. PubMed ID: 10654897
[TBL] [Abstract][Full Text] [Related]
15. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison.
Eldefrawy A; Katkoori D; Abramowitz M; Soloway MS; Manoharan M
Urol Oncol; 2013 Jul; 31(5):576-80. PubMed ID: 21616691
[TBL] [Abstract][Full Text] [Related]
16. A systematic overview of radiation therapy effects in prostate cancer.
Nilsson S; Norlén BJ; Widmark A
Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
[TBL] [Abstract][Full Text] [Related]
17. The perioperative charge equivalence of interstitial brachytherapy and radical prostatectomy with 1-year followup.
Kohan AD; Armenakas NA; Fracchia JA
J Urol; 2000 Feb; 163(2):511-4. PubMed ID: 10647667
[TBL] [Abstract][Full Text] [Related]
18. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
Morimoto M; Yoshioka Y; Konishi K; Isohashi F; Takahashi Y; Ogata T; Koizumi M; Teshima T; Bijl HP; van der Schaaf A; Langendijk JA; Ogawa K
Tumori; 2014; 100(3):265-71. PubMed ID: 25076236
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
20. [Advancement of treatment for prostate cancer].
Hara I
Gan To Kagaku Ryoho; 2006 Feb; 33(2):178-82. PubMed ID: 16484852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
